Relating mutational signature exposures to clinical data in cancers via signeR 2.0 (2023)
Fonte: BMC Bioinformatics. Unidade: FFCLRP
Assuntos: ALGORITMOS, INFERÊNCIA BAYESIANA, MUTAÇÃO, NEOPLASIAS
ABNT
DRUMMOND, Rodrigo Duarte et al. Relating mutational signature exposures to clinical data in cancers via signeR 2.0. BMC Bioinformatics, v. 24, n. 1, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.1186/s12859-023-05550-3. Acesso em: 09 nov. 2025.APA
Drummond, R. D., Defelicibus, A., Meyenberg, M., Valieris, R., Dias Neto, E., Mitrowsky, R. A. R., & Silva, I. T. da. (2023). Relating mutational signature exposures to clinical data in cancers via signeR 2.0. BMC Bioinformatics, 24( 1), 1-11. doi:10.1186/s12859-023-05550-3NLM
Drummond RD, Defelicibus A, Meyenberg M, Valieris R, Dias Neto E, Mitrowsky RAR, Silva IT da. Relating mutational signature exposures to clinical data in cancers via signeR 2.0 [Internet]. BMC Bioinformatics. 2023 ; 24( 1): 1-11.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1186/s12859-023-05550-3Vancouver
Drummond RD, Defelicibus A, Meyenberg M, Valieris R, Dias Neto E, Mitrowsky RAR, Silva IT da. Relating mutational signature exposures to clinical data in cancers via signeR 2.0 [Internet]. BMC Bioinformatics. 2023 ; 24( 1): 1-11.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1186/s12859-023-05550-3
